You’ve done everything right – the diet, the training, the lifestyle. But the fat around your midsection won’t move, your metabolism feels stuck, and your sharpness isn’t what it used to be. Tesamorelin is built for exactly this picture – and it’s the most clinically validated peptide in its class.
Protocols start at $250/month after a $599 Foundational Assessment. See full pricing
Tesamorelin is best suited for men and women over 35 who are dealing with stubborn visceral fat, early metabolic dysfunction, or unexplained cognitive changes – and who are ready for the most advanced peptide protocol available.
You may be a strong candidate if you:
Tesamorelin can be combined with BHRT depending on your full clinical picture. Our provider team will evaluate your labs, history, and goals before any protocol is built – nothing is prescribed without the complete picture.
Our Foundational Assessment is where it starts. It gives us – and you – everything we need.
There’s a specific type of fat that sits deep in the abdomen – surrounding your internal organs, driving inflammation, and quietly contributing to insulin resistance, cardiovascular risk, and metabolic dysfunction.1 It doesn’t respond to caloric restriction the way surface fat does. You can be lean everywhere else and still carry it.
That fat has a name: visceral adipose tissue. And Tesamorelin is the only peptide carrying an FDA approval specifically for reducing it — an approval granted for adults with HIV-associated lipodystrophy.23
Tesamorelin is a GHRH analog – it works by prompting your pituitary to restore the natural growth hormone pulses your body has been producing less of since your mid-30s. As growth hormone levels normalize, your body preferentially breaks down visceral fat while preserving lean muscle. The result isn’t just a change in how you look. It’s a meaningful shift in your metabolic health from the inside out.
This is the most advanced growth hormone optimization protocol offered at YoungerMeMD – and it’s built for patients who want more than maintenance.
Tesamorelin is administered five out of seven nights via subcutaneous injection. Most patients begin noticing meaningful changes within 6-12 weeks. Here’s what patients commonly report.
Visceral fat is metabolically stubborn by nature. Tesamorelin targets it directly, with clinical studies showing reductions of 15-18% in visceral adipose tissue over several months of consistent use. Patients who had plateaued on every other protocol see real, measurable progress.
As visceral fat decreases, downstream metabolic markers improve with it – triglycerides, inflammatory markers, insulin sensitivity. Patients describe a shift from feeling metabolically stuck to feeling like their body is actually cooperating again.
Tesamorelin has documented cognitive benefits – improved verbal memory and executive function – backed by published clinical data including a JAMA Neurology trial. For patients noticing early cognitive changes, this is one of the most compelling aspects of the protocol.
Optimized growth hormone release supports deep sleep and physical recovery. Patients on Tesamorelin consistently report improved sleep quality and faster bounce-back from physical demands.
Unlike caloric restriction, which often takes lean mass with it, Tesamorelin tends to preserve – and in some cases improve – lean muscle tissue as visceral fat decreases. Body composition shifts in the right direction across the board.
Visceral fat is directly linked to cardiovascular disease, type 2 diabetes, and systemic inflammation. Reducing it isn’t cosmetic – it’s one of the most impactful things you can do for your long-term health and longevity.
Every Tesamorelin prescription at YoungerMeMD is sourced exclusively from fully vetted, state-licensed 503A compounding pharmacies. Our peptides are never labeled “for research purposes.” They are compounded for prescription clinical use only – dispensed under physician supervision, prepared to strict standards for sterility, potency, and quality control.
Your metabolic health deserves pharmaceutical-grade precision. That is the only standard we use.
Tesamorelin is generally very well tolerated. Some patients may notice mild injection site irritation, fluid retention, or brief adjustment symptoms during the first few weeks as growth hormone levels normalize. These effects are typically mild and self-limited.
Tesamorelin should be used with caution in patients with active malignancy or a history of certain cancers. It should not be used during pregnancy or breastfeeding. Always inform your provider about all current medications, supplements, and existing health conditions before starting any protocol.
Clinical response is enhanced when supported by consistent sleep, stress management, regular physical activity, and balanced nutrition – all of which directly influence growth hormone dynamics and metabolic function.
The most clinically validated visceral fat reduction and metabolic optimization protocol available – physician-supervised and built around your biology.
$599
A complete assessment of:
This establishes which Tesamorelin protocol is right for your picture and determines whether you begin at the low or high dose based on your clinical presentation.
$279/month
Your foundational membership provides continuous support and medical oversight.
Your Membership Includes:
We start every patient at the low dose and assess response before making any adjustments. Most patients achieve their goals at the low dose – escalation is guided by your biology, not a default.
Low Dose Protocol – $250/month
The starting protocol for all Tesamorelin patients. Administered five out of seven nights via subcutaneous injection. For patients who respond well at this level, this remains the ongoing protocol.
High Dose Protocol – $350/month
For patients whose results plateau or who don’t achieve satisfactory progress at the low dose. Administered five out of seven nights. Escalation is always provider-directed based on clinical response monitoring.
Either protocol is deemed an ongoing treatment. Your provider team monitors response and determines the appropriate dose level based on your labs, symptoms, and body composition changes over time.
Yes – and that matters. Tesamorelin is the only GHRH analog with FDA approval specifically for visceral fat reduction — granted for adults with HIV-associated lipodystrophy — giving it one of the most well-documented clinical safety profiles among all peptides available today.42 At YoungerMeMD, it is used off-label for adult metabolic and longevity optimization under the direct supervision of Dr. Varano and his provider team.
Tesamorelin is administered via subcutaneous injection – a small, fine-needle injection given at home five out of seven nights. Our care team provides full training and is available for support as you get started.
The five-out-of-seven protocol mirrors the body’s natural growth hormone pulsatility and prevents receptor desensitization that can occur with daily use. The two rest nights allow your system to maintain sensitivity to the signal, which supports more consistent and durable results over time.
We start every patient on the low dose protocol and monitor response over the first several weeks. For patients who respond well at the lower dose, there is no need to escalate. For patients who don’t achieve satisfactory results at the lower dose, we move to the high dose protocol. This approach minimizes unnecessary exposure and lets your biology guide the escalation decision rather than starting everyone at the ceiling.
Yes. A JAMA Neurology clinical trial documented improvements in verbal memory and executive function in older adults on Tesamorelin – making it one of the few peptides with published cognitive outcome data. For patients with early cognitive concerns, this is a meaningful part of the protocol.
Absolutely. Tesamorelin fits naturally within a broader optimization protocol and can be incorporated alongside BHRT or other peptide programs depending on your goals and where you are in your health journey. Every protocol is built individually by our provider team – nothing is stacked without clinical justification.
Tesamorelin is offered through YoungerMeMD’s membership-based model, which operates outside of traditional insurance. Your membership includes physician oversight, ongoing protocol management, and the kind of personalized attention that insurance-based care isn’t designed to provide.
Tesamorelin isn’t a starting point. It’s where patients who are serious about metabolic health, body composition, and cognitive longevity arrive when they’re ready to go further than anything else has taken them.
It starts with a conversation and the right labs. From there, our provider team builds a protocol around your specific picture – not a template, not a guess.
Visceral fat and metabolic dysfunction rarely exist in isolation. These protocols address the systemic layers that determine how completely and how durably Tesamorelin's results take hold — and what becomes possible once the metabolic environment shifts.
Declining testosterone and estrogen impair how the body regulates fat distribution, metabolic rate, and insulin sensitivity. Tesamorelin addresses the growth hormone layer, while hormone optimization addresses the sex hormone layer that shapes the metabolic environment it works in.
Best for: patients over 40 whose visceral fat and metabolic decline have a clear hormonal component alongside GH deficiency
Learn about Hormone HealthVisceral fat drives chronic inflammation, which can blunt growth hormone signaling and metabolic function. Thymosin Alpha-1 helps regulate that immune overactivation, easing the inflammatory burden that keeps visceral fat resistant to treatment.
Best for: patients with elevated CRP, chronic inflammation, or autoimmune history complicating visceral fat reduction
Learn about DefendMeTesamorelin has published clinical data showing improvements in verbal memory and executive function. Pairing it with Semax adds a second pathway, supporting neuroplasticity and BDNF signaling, for patients whose goals are both cognitive and metabolic.
Best for: patients seeking both visceral fat reduction and meaningful cognitive restoration as primary goals
Learn about CognitiveMeGut dysbiosis and intestinal permeability drive systemic inflammation that impairs insulin sensitivity and contributes to visceral fat accumulation. For patients with a gut-driven component, restoring gut integrity with BPC-157 + KPV can remove a hidden barrier to Tesamorelin’s metabolic results.
Best for: patients with GI symptoms, metabolic dysfunction, or inflammatory markers suggesting a gut-driven metabolic component
Learn about Gut RestorationFill up the form below to get started
Provocation agent administered prior to timed urine collection (<6hr). Reveals toxic metal burden that can block hormone and peptide response.
Identifies gluten sensitivity, intestinal permeability (leaky gut), and wheat-related immune reactivity – distinct from standard celiac testing.
DNA Based stool test detecting pathogens, bacterial imbalances, parasites, and digestive markers – a comprehensive gut microbiome assessment.
Non-invasive carotid artery ultrasound measuring arterial wall thickness – a direct look at your cardiovascular age.
Cardio Res-Q cardiac risk panel – inflammation markers and cardiovascular biomarkers beyond standard labs.
Evaluates intracellular vitamin, mineral, and antioxidant status – foundational to optimizing cellular health and peptide efficacy.
Full Sex hormone, thyroid and adrenal picture. Identifies imbalances that affect energy, recovery, cognition, and peptide response.
Advanced testing for immune reactions to wheat, gluten, and intestinal permeability.
What It Evaluates
Heavy metals like mercury, lead, cadmium, arsenic, and aluminum can cause:
Conditions We Identify
